BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32457180)

  • 1. Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank.
    Watts EL; Perez-Cornago A; Kothari J; Allen NE; Travis RC; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1615-1626. PubMed ID: 32457180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank.
    Watts EL; Fensom GK; Smith Byrne K; Perez-Cornago A; Allen NE; Knuppel A; Gunter MJ; Holmes MV; Martin RM; Murphy N; Tsilidis KK; Yeap BB; Key TJ; Travis RC
    Int J Cancer; 2021 May; 148(9):2274-2288. PubMed ID: 33252839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank.
    Watts EL; Perez-Cornago A; Knuppel A; Tsilidis KK; Key TJ; Travis RC
    Int J Cancer; 2021 Aug; 149(3):573-584. PubMed ID: 33720423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.
    Perez-Cornago A; Fensom GK; Andrews C; Watts EL; Allen NE; Martin RM; Van Hemelrijck M; Key TJ; Travis RC
    Br J Cancer; 2020 Dec; 123(12):1808-1817. PubMed ID: 32963348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood cell indices and inflammation-related markers with kidney cancer risk: a large-population prospective analysis in UK Biobank.
    He Q; Wei C; Cao L; Zhang P; Zhuang W; Cai F
    Front Oncol; 2024; 14():1366449. PubMed ID: 38846978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies.
    Perez-Cornago A; Dunneram Y; Watts EL; Key TJ; Travis RC
    BMC Med; 2022 May; 20(1):143. PubMed ID: 35509091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
    Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
    Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of Glucose Homeostasis and Inflammation with Risk of Prostate Cancer: A Case-Cohort Study.
    Wang Y; Gapstur SM; Newton CC; McCullough ML; Pollak MN; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):736-743. PubMed ID: 35149581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Specific Associations of Testosterone and Genetic Factors With Health Span.
    Zhao X; Liang S; Wang N; Hong T; Sambou ML; Fan J; Zhu M; Wang C; Hang D; Jiang Y; Dai J
    Front Endocrinol (Lausanne); 2021; 12():773464. PubMed ID: 34899607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediagnostic circulating markers of inflammation and risk of prostate cancer.
    Toriola AT; Laukkanen JA; Kurl S; Nyyssönen K; Ronkainen K; Kauhanen J
    Int J Cancer; 2013 Dec; 133(12):2961-7. PubMed ID: 23754532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database.
    Vidal AC; Howard LE; de Hoedt A; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Taioli E; Fowke JH; Freedland SJ
    Cancer Causes Control; 2018 Jun; 29(6):581-588. PubMed ID: 29663110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
    Cooperberg MR; Zheng Y; Faino AV; Newcomb LF; Zhu K; Cowan JE; Brooks JD; Dash A; Gleave ME; Martin F; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Carroll PR; Lin DW
    JAMA Oncol; 2020 Oct; 6(10):e203187. PubMed ID: 32852532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer.
    Marrone MT; Selvin E; Barber JR; Platz EA; Joshu CE
    Cancer Prev Res (Phila); 2019 Feb; 12(2):103-112. PubMed ID: 30538098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and prostate cancer survival and recurrence.
    Kenfield SA; Stampfer MJ; Chan JM; Giovannucci E
    JAMA; 2011 Jun; 305(24):2548-55. PubMed ID: 21693743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
    Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study.
    Perez-Cornago A; Key TJ; Allen NE; Fensom GK; Bradbury KE; Martin RM; Travis RC
    Br J Cancer; 2017 Nov; 117(10):1562-1571. PubMed ID: 28910820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.
    Taussky D; Souliéres D; Azoulay L; Yin H; Bahig H; Bahary JP; Delouya G
    Target Oncol; 2017 Oct; 12(5):695-701. PubMed ID: 28712059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality.
    Langlais CS; Graff RE; Van Blarigan EL; Kenfield SA; Neuhaus J; Tabung FK; Cowan JE; Broering JM; Carroll P; Chan JM
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1760-1768. PubMed ID: 35767977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank.
    Monroy-Iglesias MJ; Russell B; Crawley D; Allen NE; Travis RC; Perez-Cornago A; Van Hemelrijck M; Beckmann K
    Int J Cancer; 2021 Feb; 148(4):825-834. PubMed ID: 33405276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.